Nuveen Asset Management, LLC Kaleido Biosciences, Inc. Transaction History

Nuveen Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.05 - $1.7 $2,944 - $100,107	-58,887 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$5.36 - $7.99 $106,948 - $159,424	-19,953 Reduced 25.31%	58,887 $343,000
Q2 2021 Aug 16, 2021	BUY	$5.82 - $8.72 $80,898 - $121,208	13,900 Added 21.4%	78,840 $586,000
Q1 2021 May 17, 2021	SELL	$7.2 - $16.82 $9,871 - $23,060	-1,371 Reduced 2.07%	64,940 $526,000
Q4 2020 Feb 16, 2021	BUY	$5.77 - $11.33 $52,420 - $102,933	9,085 Added 15.88%	66,311 $603,000
Q3 2020 Nov 16, 2020	BUY	$5.09 - $11.07 $1,460 - $3,177	287 Added 0.5%	57,226 $633,000
Q2 2020 Aug 14, 2020	BUY	$4.62 - $8.01 $128,246 - $222,349	27,759 Added 95.13%	56,939 $423,000
Q1 2020 May 14, 2020	BUY	$3.62 - $9.49 $105,631 - $276,918	29,180 New	29,180 $179,000

2.65K

Ticker KLDO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,622,600
Description
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.